First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
作者： Alan I Green , Mauricio F Tohen , Robert M Hamer , Stephen M Strakowski , Jeffrey A Lieberman
DOI: 10.1016/J.SCHRES.2003.08.001
关键词: Psychiatry 、 Olanzapine 、 Psychosis 、 Cannabis 、 Haloperidol 、 Schizophreniform disorder 、 First episode 、 Psychology 、 Substance abuse 、 Schizophrenia
摘要: Background: Co-occurring substance use disorders, mostly involving alcohol, cannabis or cocaine, occur commonly in patients with schizophrenia and are associated increased morbidity mortality. Available but limited data suggest that disorders (especially disorders) may also be common first-episode appear linked to a poor outcome these patients. Strategies curtail form an important dimension of the treatment program for both chronic We report on rates co-occurring within their first episode schizophrenia-related psychosis from multicenter, international trial olanzapine vs. haloperidol.
elsevier.com
sci-hub.se 参考文章(57)
Marijuana use in schizophrenia: a clear hazard. American Journal of Psychiatry. ,vol. 135, pp. 1213- 1215 ,(1978) , 10.1176/AJP.135.10.1213
Max Birchwood, Pauline Todd, Chris Jackson, Early intervention in psychosis: The critical period hypothesis The British journal of psychiatry. Supplement. ,vol. 172, pp. 53- 59 ,(1998) , 10.1192/S0007125000297663
Robert E. Drake, Mary F. Brunette, Complications of Severe Mental Illness Related to Alcohol and Drug Use Disorders Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism. ,vol. 14, pp. 285- 299 ,(1998) , 10.1007/0-306-47148-5_12
The Self-Medication Hypothesis of Addictive Disorders: Focus on Heroin and Cocaine Dependence American Journal of Psychiatry. ,vol. 142, pp. 1259- 1264 ,(1985) , 10.1176/AJP.142.11.1259
Douglas Jacobs, The Harvard Medical School guide to suicide assessment and intervention. Jossey-Bass. ,(1999)
B Bühler, Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research. ,vol. 54, pp. 243- 251 ,(2002) , 10.1016/S0920-9964(01)00249-3
M. Moscarelli, S. Capri, L. Neri, Cost Evaluation of Chronic Schizophrenic Patients During the First 3 Years After the First Contact Schizophrenia Bulletin. ,vol. 17, pp. 421- 426 ,(1991) , 10.1093/SCHBUL/17.3.421
B. Kovasznay, J. Fleischer, M. Tanenberg-Karant, L. Jandorf, A. D. Miller, E. Bromet, Substance Use Disorder and the Early Course of Illness in Schizophrenia and Affective Psychosis Schizophrenia Bulletin. ,vol. 23, pp. 195- 201 ,(1997) , 10.1093/SCHBUL/23.2.195
P. Knudsen, T. Vilmar, Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica. ,vol. 69, pp. 162- 174 ,(1984) , 10.1111/J.1600-0447.1984.TB02482.X
Cedric M. Smith, Drew Barzman, Cynthia A. Pristach, Effect of Patient and Family Insight on Compliance of Schizophrenic Patients The Journal of Clinical Pharmacology. ,vol. 37, pp. 147- 154 ,(1997) , 10.1002/J.1552-4604.1997.TB04773.X